propofol has been researched along with Maxillary Diseases in 2 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Maxillary Diseases: Diseases involving the MAXILLA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawaguchi, Y | 1 |
| Ishihara, H | 1 |
| Kushikata, T | 1 |
| Kitayama, M | 1 |
| Hirota, K | 1 |
| Jorgensen, BG | 1 |
| Laub, M | 1 |
| Knudsen, RH | 1 |
2 other studies available for propofol and Maxillary Diseases
| Article | Year |
|---|---|
[Plasma concentration of propofol was 4.4 microg x ml(-1), 4.5 hours after completion of its administration].
Topics: Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Intravenous; Delayed Emergence from An | 2010 |
Anaesthetic implications of rigid spine syndrome.
Topics: Adolescent; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Contracture; Fem | 1999 |